FDA Established Pharmacologic Classes
Drug classes
307 FDA pharmacologic classes, each with its medicines, generics and pharmacy prices (FDA NDC Directory, October 8, 2026).
Every class
- 5-alpha reductase inhibitors
- 3 medicines; FDA: 5-alpha Reductase Inhibitor
- ACE inhibitors
- 19 medicines; FDA: Angiotensin Converting Enzyme Inhibitor
- Acetylcholine Release Inhibitor
- 3 medicines
- Adenosine Receptor Agonist
- 2 medicines
- Adrenocorticotropic Hormone
- 2 medicines
- Aldosterone antagonists
- 3 medicines; FDA: Aldosterone Antagonist
- Alkaloid
- 2 medicines
- Alkylating Drug
- 16 medicines
- Allylamine Antifungal
- 2 medicines
- Alpha blockers
- 10 medicines; FDA: alpha-Adrenergic Blocker
- alpha-1 Adrenergic Agonist
- 7 medicines
- alpha-Adrenergic Agonist
- 22 medicines
- alpha-Glucosidase Inhibitor
- 2 medicines
- Amide Local Anesthetic
- 13 medicines
- Amino Acid
- 11 medicines
- Aminoglycoside Antibacterial
- 15 medicines
- Aminoketone
- 3 medicines
- Aminosalicylate
- 4 medicines
- Androgen Receptor Inhibitor
- 5 medicines
- Androgens
- 3 medicines; FDA: Androgen
- Anthelmintic
- 4 medicines
- Anthracycline Topoisomerase Inhibitor
- 5 medicines
- Anthrax Protective Antigen-directed Antibody
- 2 medicines
- Anti-coagulant
- 25 medicines
- Anti-seizure medicines
- 14 medicines; FDA: Anti-epileptic Agent
- Antiarrhythmic
- 17 medicines
- Anticholinergics
- 24 medicines; FDA: Anticholinergic
- Antidiarrheal
- 3 medicines
- Antidote
- 3 medicines
- Antiemetic
- 2 medicines
- Antifibrinolytic Agent
- 2 medicines
- Antihistamines
- 4 medicines; FDA: Antihistamine
- Antihistamines (H1 blockers)
- 22 medicines; FDA: Histamine-1 Receptor Antagonist
- Antihypoglycemic Agent
- 2 medicines
- Antimalarial
- 8 medicines
- Antimetabolite
- 3 medicines
- Antimetabolite Immunosuppressant
- 2 medicines
- Antimycobacterial
- 6 medicines
- Antiprotozoal
- 7 medicines
- Antirheumatic Agent
- 3 medicines
- Antisense Oligonucleotide
- 7 medicines
- Antithyroid medicines
- 2 medicines; FDA: Thyroid Hormone Synthesis Inhibitor
- APOC-III-directed RNA Interaction
- 2 medicines
- ARBs (angiotensin II receptor blockers)
- 22 medicines; FDA: Angiotensin 2 Receptor Blocker
- Aromatase inhibitors
- 3 medicines; FDA: Aromatase Inhibitor
- Aromatic Amino Acid
- 3 medicines
- Arteriolar Vasodilator
- 4 medicines
- Asparagine-specific Enzyme
- 3 medicines
- Atypical antipsychotics
- 17 medicines; FDA: Atypical Antipsychotic
- Azole antifungals
- 20 medicines; FDA: Azole Antifungal
- Barbiturates
- 6 medicines; FDA: Barbiturate
- Benzodiazepines
- 16 medicines; FDA: Benzodiazepine
- Beta blockers
- 21 medicines; FDA: beta-Adrenergic Blocker
- beta Lactamase Inhibitor
- 8 medicines
- Beta-2 agonists (bronchodilators)
- 18 medicines; FDA: beta2-Adrenergic Agonist
- beta-Adrenergic Agonist
- 8 medicines
- beta3-Adrenergic Agonist
- 2 medicines
- Biguanides (metformin)
- 13 medicines; FDA: Biguanide
- Bile Acid
- 3 medicines
- Bile Acid Sequestrant
- 3 medicines
- Bispecific CD20-directed CD3 T Cell Engager
- 2 medicines
- Bisphosphonates
- 6 medicines; FDA: Bisphosphonate
- Blood Coagulation Factor
- 19 medicines
- Calcineurin Inhibitor Immunosuppressant
- 4 medicines
- Calcium channel blockers
- 12 medicines; FDA: Calcium Channel Blocker
- Calcium channel blockers (dihydropyridines)
- 16 medicines; FDA: Dihydropyridine Calcium Channel Blocker
- Calcium-sensing Receptor Agonist
- 2 medicines
- Calculi Dissolution Agent
- 44 medicines
- Carbonic Anhydrase Inhibitor
- 6 medicines
- Catechol-O-Methyltransferase Inhibitor
- 4 medicines
- Catecholamine
- 7 medicines
- CD20-directed Cytolytic Antibody
- 7 medicines
- CD38-directed Cytolytic Antibody
- 3 medicines
- Central alpha-2 Adrenergic Agonist
- 5 medicines
- Central Nervous System Depressant
- 2 medicines
- Cephalosporins
- 21 medicines; FDA: Cephalosporin Antibacterial
- Cholinergic Muscarinic Agonist
- 2 medicines
- Cholinergic Muscarinic Antagonist
- 15 medicines
- Cholinergic Receptor Agonist
- 7 medicines
- Cholinesterase inhibitors
- 8 medicines; FDA: Cholinesterase Inhibitor
- Complement Inhibitor
- 6 medicines
- Contrast Agent for Ultrasound Imaging
- 3 medicines
- Copper Absorption Inhibitor
- 3 medicines
- Corticosteroids
- 55 medicines; FDA: Corticosteroid
- Cortisol Synthesis Inhibitor
- 2 medicines
- CTLA-4-directed Blocking Antibody
- 2 medicines
- Cyclooxygenase Inhibitor
- 2 medicines
- Cytochrome P450 17A1 Inhibitor
- 2 medicines
- Cytochrome P450 2D6 Inhibitor
- 2 medicines
- Cytochrome P450 3A Inhibitor
- 8 medicines
- Cytoprotective Agent
- 4 medicines
- Diagnostic Dye
- 5 medicines
- Dietary Cholesterol Absorption Inhibitor
- 3 medicines
- Direct thrombin inhibitors
- 3 medicines; FDA: Direct Thrombin Inhibitor
- Dopamine-2 Receptor Antagonist
- 3 medicines
- DPP-4 inhibitors
- 12 medicines; FDA: Dipeptidyl Peptidase 4 Inhibitor
- Echinocandin Antifungal
- 4 medicines
- Endoglycosidase
- 11 medicines
- Endothelin Receptor Antagonist
- 7 medicines
- Epidermal Growth Factor Receptor Antagonist
- 2 medicines
- Ergot Derivative
- 3 medicines
- Ergotamine Derivative
- 3 medicines
- Erythropoiesis-stimulating Agent
- 3 medicines
- Ester Local Anesthetic
- 3 medicines
- Estrogen Agonist/Antagonist
- 6 medicines
- Estrogen Receptor Antagonist
- 3 medicines
- Estrogens
- 15 medicines; FDA: Estrogen
- Expectorant
- 4 medicines
- Factor Xa inhibitors
- 4 medicines; FDA: Factor Xa Inhibitor
- Fluoroquinolones
- 6 medicines; FDA: Fluoroquinolone Antibacterial
- Folate Analog
- 2 medicines
- Folate Analog Metabolic Inhibitor
- 3 medicines
- Gadolinium-based Contrast Agent
- 4 medicines
- gamma-Aminobutyric Acid-ergic Agonist
- 2 medicines
- General Anesthetic
- 6 medicines
- Glinide
- 2 medicines
- GLP-1 receptor agonists
- 8 medicines; FDA: GLP-1 Receptor Agonist
- Glucosylceramide Synthase Inhibitor
- 2 medicines
- Gonadotropin
- 2 medicines
- Guanylate Cyclase-C Agonist
- 2 medicines
- H2 blockers
- 6 medicines; FDA: Histamine-2 Receptor Antagonist
- Hedgehog Pathway Inhibitor
- 3 medicines
- Hepatitis C Virus NS3/4A Protease Inhibitor
- 3 medicines
- Hepatitis C Virus NS5A Inhibitor
- 5 medicines
- HER2/neu Receptor Antagonist
- 9 medicines
- Histamine-1 Receptor Inhibitor
- 4 medicines
- Histone Deacetylase Inhibitor
- 4 medicines
- Human Immunoglobulin G
- 3 medicines
- Ileal Bile Acid Transporter Inhibitor
- 3 medicines
- Influenza A M2 Protein Inhibitor
- 2 medicines
- Insulin Analog
- 9 medicines
- Integrin Receptor Antagonist
- 2 medicines
- Interferon beta
- 2 medicines
- Interleukin-12 Antagonist
- 3 medicines
- Interleukin-13 Antagonist
- 2 medicines
- Interleukin-17A Antagonist
- 2 medicines
- Interleukin-23 Antagonist
- 7 medicines
- Interleukin-5 Antagonist
- 2 medicines
- Interleukin-6 Receptor Antagonist
- 2 medicines
- Iron Chelator
- 3 medicines
- Isocitrate Dehydrogenase 1 Inhibitor
- 2 medicines
- Isocitrate Dehydrogenase 2 Inhibitor
- 2 medicines
- Janus Kinase Inhibitor
- 7 medicines
- Kinase inhibitors
- 73 medicines; FDA: Kinase Inhibitor
- Lead Chelator
- 3 medicines
- Leukocyte Growth Factor
- 5 medicines
- Leukotriene receptor antagonists
- 2 medicines; FDA: Leukotriene Receptor Antagonist
- Lincosamide Antibacterial
- 4 medicines
- Lipid Emulsion
- 4 medicines
- Lipoglycopeptide Antibacterial
- 3 medicines
- Loop diuretics
- 4 medicines; FDA: Loop Diuretic
- Low Molecular Weight Heparin
- 2 medicines
- Macrolide
- 2 medicines
- Macrolides
- 4 medicines; FDA: Macrolide Antimicrobial
- MAO inhibitors
- 5 medicines; FDA: Monoamine Oxidase Inhibitor
- Mast Cell Stabilizer
- 3 medicines
- Melatonin Receptor Agonist
- 2 medicines
- Menin Inhibitor
- 2 medicines
- Methylxanthine
- 11 medicines
- Microtubule Inhibitor
- 4 medicines
- Monoamine Oxidase Type B Inhibitor
- 2 medicines
- Monobactam Antibacterial
- 2 medicines
- Mood Stabilizer
- 5 medicines
- mTOR Inhibitor Immunosuppressant
- 2 medicines
- Muscle relaxants
- 7 medicines; FDA: Muscle Relaxant
- N-methyl-D-aspartate Receptor Antagonist
- 2 medicines
- Neonatal Fc Receptor Blocker
- 3 medicines
- Neuraminidase Inhibitor
- 2 medicines
- Neuromuscular Blocker
- 2 medicines
- Nitrate Vasodilator
- 4 medicines
- Nitrogen Binding Agent
- 3 medicines
- Nitroimidazole Antimicrobial
- 5 medicines
- Nondepolarizing Neuromuscular Blocker
- 4 medicines
- Nonergot Dopamine Agonist
- 3 medicines
- Norepinephrine Reuptake Inhibitor
- 2 medicines
- NSAIDs (nonsteroidal anti-inflammatory drugs)
- 44 medicines; FDA: Nonsteroidal Anti-inflammatory Drug
- Nucleoside Analog Antiviral
- 5 medicines
- Nucleoside Metabolic Inhibitor
- 15 medicines
- Opioid Agonist/Antagonist
- 2 medicines
- Opioid antagonists
- 11 medicines; FDA: Opioid Antagonist
- Opioids (opioid agonists)
- 30 medicines; FDA: Opioid Agonist
- Optical Imaging Agent
- 2 medicines
- Orexin Receptor Antagonist
- 3 medicines
- Osmotic Diuretic
- 2 medicines
- Osmotic Laxative
- 50 medicines
- Oxazolidinone Antibacterial
- 2 medicines
- P2Y12 inhibitors (antiplatelets)
- 4 medicines; FDA: P2Y12 Platelet Inhibitor
- Paramagnetic Contrast Agent
- 4 medicines
- Parathyroid Hormone Analog
- 2 medicines
- Parenteral Iron Replacement
- 8 medicines
- Partial opioid agonists
- 2 medicines; FDA: Partial Opioid Agonist
- PCSK9 inhibitors
- 2 medicines; FDA: PCSK9 Inhibitor
- PDE5 inhibitors
- 5 medicines; FDA: Phosphodiesterase 5 Inhibitor
- Pediculicide
- 2 medicines
- Penem Antibacterial
- 5 medicines
- Penicillins
- 13 medicines; FDA: Penicillin-class Antibacterial
- Phenothiazine
- 12 medicines
- Phosphate Binder
- 29 medicines
- Phosphodiesterase 3 Inhibitor
- 3 medicines
- Phosphodiesterase 4 Inhibitor
- 5 medicines
- Photoactivated Radical Generator
- 2 medicines
- Plasma Kallikrein Inhibitor
- 4 medicines
- Plasma Volume Expander
- 2 medicines
- Platelet Aggregation Inhibitor
- 9 medicines
- Platinum-based Drug
- 3 medicines
- Poly(ADP-Ribose) Polymerase Inhibitor
- 5 medicines
- Polyene Antifungal
- 3 medicines
- Polymyxin-class Antibacterial
- 10 medicines
- Potassium Binder
- 2 medicines
- Potassium Channel Blocker
- 2 medicines
- Potassium Salt
- 32 medicines
- Potassium-sparing Diuretic
- 4 medicines
- Progestin-containing Intrauterine System
- 3 medicines
- Progestins
- 16 medicines; FDA: Progestin
- Programmed Death Ligand-1 Blocker
- 3 medicines
- Programmed Death Receptor-1 Blocking Antibody
- 11 medicines
- Prostacycline Vasodilator
- 3 medicines
- Prostaglandin Analog
- 8 medicines
- Prostaglandin E1 Analog
- 2 medicines
- Protease Inhibitor
- 9 medicines
- Proteasome Inhibitor
- 3 medicines
- Proton pump inhibitors (PPIs)
- 9 medicines; FDA: Proton Pump Inhibitor
- Purine Antimetabolite
- 2 medicines
- Quinolone Antimicrobial
- 7 medicines
- Radioactive Diagnostic Agent
- 25 medicines
- Radiographic Contrast Agent
- 12 medicines
- Recombinant Human Growth Hormone
- 3 medicines
- Renal Dehydropeptidase Inhibitor
- 2 medicines
- Retinoid
- 15 medicines
- Rho Kinase Inhibitor
- 2 medicines
- Rifamycin Antibacterial
- 2 medicines
- Rifamycin Antimycobacterial
- 3 medicines
- Sclerosing Agent
- 2 medicines
- Serotonin Reuptake Inhibitor
- 9 medicines
- Serotonin-3 Receptor Antagonist
- 6 medicines
- SGLT2 inhibitors
- 11 medicines; FDA: Sodium-Glucose Cotransporter 2 Inhibitor
- Sigma-1 Agonist
- 7 medicines
- Skin Test Antigen
- 2 medicines
- Small Interfering RNA
- 5 medicines
- SNRIs (serotonin and norepinephrine reuptake inhibitors)
- 5 medicines; FDA: Serotonin and Norepinephrine Reuptake Inhibitor
- Soluble Guanylate Cyclase Stimulator
- 2 medicines
- Somatostatin Analog
- 3 medicines
- Sphingosine 1-phosphate Receptor Modulator
- 5 medicines
- Statins
- 9 medicines; FDA: HMG-CoA Reductase Inhibitor
- Stimulants
- 17 medicines; FDA: Central Nervous System Stimulant
- Substance P/Neurokinin-1 Receptor Antagonist
- 5 medicines
- Sulfonamide Antibacterial
- 4 medicines
- Sulfonylureas
- 6 medicines; FDA: Sulfonylurea
- Surfactant
- 3 medicines
- Sympathomimetic Amine Anorectic
- 5 medicines
- Tetracycline-class Antibacterial
- 3 medicines
- Tetracycline-class Antimicrobial
- 3 medicines
- Tetracyclines
- 3 medicines; FDA: Tetracycline-class Drug
- Thalidomide Analog
- 2 medicines
- Thiazide diuretics
- 21 medicines; FDA: Thiazide Diuretic
- Thiazide-like diuretics
- 6 medicines; FDA: Thiazide-like Diuretic
- Thiazolidinediones
- 4 medicines; FDA: Thiazolidinedione
- Thrombopoietin Receptor Agonist
- 2 medicines
- TNF blockers
- 7 medicines; FDA: Tumor Necrosis Factor Blocker
- Topoisomerase Inhibitor
- 4 medicines
- Transthyretin-directed RNA Interaction
- 3 medicines
- Tricyclic antidepressants
- 11 medicines; FDA: Tricyclic Antidepressant
- Triptans
- 9 medicines; FDA: Serotonin-1b and Serotonin-1d Receptor Agonist
- Typical antipsychotics
- 4 medicines; FDA: Typical Antipsychotic
- Unfractionated Heparin
- 3 medicines
- Vascular Endothelial Growth Factor Inhibitor
- 5 medicines
- Vasoconstrictor
- 2 medicines
- Vasodilator
- 2 medicines
- Vesicular Monoamine Transporter 2 Inhibitor
- 2 medicines
- Vinca Alkaloid
- 3 medicines
- Vitamin B12
- 3 medicines
- Vitamin B6 Analog
- 3 medicines
- Vitamin C
- 4 medicines
- Vitamin D
- 3 medicines
- Vitamin D Analog
- 3 medicines
- Vitamin D2 Analog
- 2 medicines
- Vitamin D3 Analog
- 3 medicines
- Vitamin K
- 3 medicines
- Warfarin Reversal Agent
- 3 medicines
- Xanthine oxidase inhibitors
- 2 medicines; FDA: Xanthine Oxidase Inhibitor
Source: FDA NDC Directory (pharmacologic classes) via openFDA